Cargando…
Is there a moderate range of impact of financialization on corporate R&D?
How to promote corporate research and development is a particularly important issue under the background of the economy being diverted out of the real economy. By selecting samples of 1221 Chinese A-share non-financial listed companies from 2010 to 2019, this paper examines the impact of financializ...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244881/ https://www.ncbi.nlm.nih.gov/pubmed/34191824 http://dx.doi.org/10.1371/journal.pone.0253380 |
_version_ | 1783716013182812160 |
---|---|
author | Li, Zhenghui Wang, Yan |
author_facet | Li, Zhenghui Wang, Yan |
author_sort | Li, Zhenghui |
collection | PubMed |
description | How to promote corporate research and development is a particularly important issue under the background of the economy being diverted out of the real economy. By selecting samples of 1221 Chinese A-share non-financial listed companies from 2010 to 2019, this paper examines the impact of financialization on research and development through the panel threshold regression model. Then, the moderate range of the impact of financialization on corporate research and development is measured, as well as their heterogeneity is also analyzed. The research shows the following results: first, there is a dynamic relationship and moderate range between financialization and corporate research and development. Financialization has a positive effect on corporate research and development when the level of financialization exceeds 0.4748. Secondly, from further heterogeneous research, financialization has a threshold effect on research and development among enterprises with a high level of research and development. In addition, there is a promoting effect on corporate research and development only when their financialization level exceeds 0.0097 in enterprises with a high level of research and development. Therefore, in order to promote corporate research and development, financialization of non-financial enterprises should make adjustment and regulation according to the action and direction of moderate range. |
format | Online Article Text |
id | pubmed-8244881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-82448812021-07-12 Is there a moderate range of impact of financialization on corporate R&D? Li, Zhenghui Wang, Yan PLoS One Research Article How to promote corporate research and development is a particularly important issue under the background of the economy being diverted out of the real economy. By selecting samples of 1221 Chinese A-share non-financial listed companies from 2010 to 2019, this paper examines the impact of financialization on research and development through the panel threshold regression model. Then, the moderate range of the impact of financialization on corporate research and development is measured, as well as their heterogeneity is also analyzed. The research shows the following results: first, there is a dynamic relationship and moderate range between financialization and corporate research and development. Financialization has a positive effect on corporate research and development when the level of financialization exceeds 0.4748. Secondly, from further heterogeneous research, financialization has a threshold effect on research and development among enterprises with a high level of research and development. In addition, there is a promoting effect on corporate research and development only when their financialization level exceeds 0.0097 in enterprises with a high level of research and development. Therefore, in order to promote corporate research and development, financialization of non-financial enterprises should make adjustment and regulation according to the action and direction of moderate range. Public Library of Science 2021-06-30 /pmc/articles/PMC8244881/ /pubmed/34191824 http://dx.doi.org/10.1371/journal.pone.0253380 Text en © 2021 Li, Wang https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Li, Zhenghui Wang, Yan Is there a moderate range of impact of financialization on corporate R&D? |
title | Is there a moderate range of impact of financialization on corporate R&D? |
title_full | Is there a moderate range of impact of financialization on corporate R&D? |
title_fullStr | Is there a moderate range of impact of financialization on corporate R&D? |
title_full_unstemmed | Is there a moderate range of impact of financialization on corporate R&D? |
title_short | Is there a moderate range of impact of financialization on corporate R&D? |
title_sort | is there a moderate range of impact of financialization on corporate r&d? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244881/ https://www.ncbi.nlm.nih.gov/pubmed/34191824 http://dx.doi.org/10.1371/journal.pone.0253380 |
work_keys_str_mv | AT lizhenghui isthereamoderaterangeofimpactoffinancializationoncorporaterd AT wangyan isthereamoderaterangeofimpactoffinancializationoncorporaterd |